Cargando…

SARS-CoV-2 Variants of Concern and Variants of Interest Receptor Binding Domain Mutations and Virus Infectivity

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic has lasted more than 2 years with over 260 million infections and 5 million deaths worldwide as of November 2021. To combat the virus, monoclonal antibodies blocking the virus binding to human receptor, the angiotensin convert...

Descripción completa

Detalles Bibliográficos
Autores principales:	Liu, Haolin, Wei, Pengcheng, Kappler, John W., Marrack, Philippa, Zhang, Gongyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Immunology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8828474/ https://www.ncbi.nlm.nih.gov/pubmed/35154144 http://dx.doi.org/10.3389/fimmu.2022.825256

Ejemplares similares

The Receptor Binding Domain of SARS-CoV-2 Lambda Variant Has a Better Chance Than the Delta Variant in Evading BNT162b2 COVID-19 mRNA Vaccine-Induced Humoral Immunity
por: Liu, Haolin, et al.
Publicado: (2022)

501Y.V2 and 501Y.V3 variants of SARS-CoV-2 lose binding to bamlanivimab in vitro
por: Liu, Haolin, et al.
Publicado: (2021)

The Lambda variant of SARS-CoV-2 has a better chance than the Delta variant to escape vaccines
por: Liu, Haolin, et al.
Publicado: (2021)

The basis of a more contagious 501Y.V1 variant of SARS-CoV-2
por: Liu, Haolin, et al.
Publicado: (2021)

Understanding the Secret of SARS-CoV-2 Variants of Concern/Interest and Immune Escape
por: Lou, Fuxing, et al.
Publicado: (2021)

Single-Domain Antibodies Efficiently Neutralize SARS-CoV-2 Variants of Concern
por: Favorskaya, Irina A., et al.
Publicado: (2022)

Functional Effects of Receptor-Binding Domain Mutations of SARS-CoV-2 B.1.351 and P.1 Variants
por: Bayarri-Olmos, Rafael, et al.
Publicado: (2021)

A Stabilized, Monomeric, Receptor Binding Domain Elicits High-Titer Neutralizing Antibodies Against All SARS-CoV-2 Variants of Concern
por: Ahmed, Shahbaz, et al.
Publicado: (2021)

Equine Anti-SARS-CoV-2 Serum (ECIG) Binds to Mutated RBDs and N Proteins of Variants of Concern and Inhibits the Binding of RBDs to ACE-2 Receptor
por: Andrade, Sonia Aparecida, et al.
Publicado: (2022)

The Emerging Concern and Interest SARS-CoV-2 Variants
por: Janik, Edyta, et al.
Publicado: (2021)

A Rapid Method to Characterize Mouse IgG Antibodies and Isolate Native Antigen Binding IgG B Cell Hybridomas
por: Liu, Haolin, et al.
Publicado: (2015)

Structural analysis of receptor binding domain mutations in SARS-CoV-2 variants of concern that modulate ACE2 and antibody binding
por: Mannar, Dhiraj, et al.
Publicado: (2021)

Display of receptor-binding domain of SARS-CoV-2 Spike protein variants on the Saccharomyces cerevisiae cell surface
por: Xing, Hongguan, et al.
Publicado: (2022)

SARS-CoV-2’s Variants of Concern: A Brief Characterization
por: Scovino, Aline Miranda, et al.
Publicado: (2022)

Epitope Classification and RBD Binding Properties of Neutralizing Antibodies Against SARS-CoV-2 Variants of Concern
por: Deshpande, Ashlesha, et al.
Publicado: (2021)

Differential activation of human neutrophils by SARS-CoV-2 variants of concern
por: Lebourgeois, Samuel, et al.
Publicado: (2022)

Quantitative Mutation Analysis of Genes and Proteins of Major SARS-CoV-2 Variants of Concern and Interest
por: Liang, Fengyi
Publicado: (2023)

Computational design of novel nanobodies targeting the receptor binding domain of variants of concern of SARS-CoV-2
por: Longsompurana, Phoomintara, et al.
Publicado: (2023)

CD8(+) T-cell immune escape by SARS-CoV-2 variants of concern
por: Kombe Kombe, Arnaud John, et al.
Publicado: (2022)

Insights on the mutational landscape of the SARS-CoV-2 Omicron variant receptor-binding domain
por: Miller, Nathaniel L., et al.
Publicado: (2022)

A vaccine based on the yeast-expressed receptor-binding domain (RBD) elicits broad immune responses against SARS-CoV-2 variants
por: Liu, Yu, et al.
Publicado: (2022)

SARS-COV-2 RBD (Receptor binding domain) mutations and variants (A sectional-analytical study)
por: Hajizadeh, Faezeh, et al.
Publicado: (2022)

A Routine Sanger Sequencing Target Specific Mutation Assay for SARS-CoV-2 Variants of Concern and Interest
por: Lee, Sin Hang
Publicado: (2021)

Broad immunity to SARS-CoV-2 variants of concern mediated by a SARS-CoV-2 receptor-binding domain protein vaccine
por: Deliyannis, Georgia, et al.
Publicado: (2023)

Editorial: Revised World Health Organization (WHO) Terminology for Variants of Concern and Variants of Interest of SARS-CoV-2
por: Parums, Dinah V.
Publicado: (2021)

Recognition of Variants of Concern by Antibodies and T Cells Induced by a SARS-CoV-2 Inactivated Vaccine
por: Melo-González, Felipe, et al.
Publicado: (2021)

SARS-CoV-2 bivalent mRNA vaccine with broad protection against variants of concern
por: Ma, Qinhai, et al.
Publicado: (2023)

Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses
por: Feldman, Jared, et al.
Publicado: (2021)

Naive human B cells engage the receptor binding domain of SARS-CoV-2, variants of concern, and related sarbecoviruses
por: Feldman, Jared, et al.
Publicado: (2021)

A Vaccine with Multiple Receptor-Binding Domain Subunit Mutations Induces Broad-Spectrum Immune Response against SARS-CoV-2 Variants of Concern
por: Hou, Xu-Chen, et al.
Publicado: (2022)

Genome Sequences of SARS-CoV-2 P.1 (Variant of Concern) and P.2 (Variant of Interest) Identified in Uruguay
por: Panzera, Yanina, et al.
Publicado: (2021)

Potent neutralization of SARS‐CoV‐2 including variants of concern by vaccines presenting the receptor‐binding domain multivalently from nanoscaffolds
por: Halfmann, Peter J., et al.
Publicado: (2021)

Pharmacoinformatic approach to identify potential phytochemicals against SARS-CoV-2 spike receptor-binding domain in native and variants of concern
por: Chinnadurai, Raj Kumar, et al.
Publicado: (2022)

Stabilization of the SARS-CoV-2 Spike Receptor-Binding Domain Using Deep Mutational Scanning and Structure-Based Design
por: Ellis, Daniel, et al.
Publicado: (2021)

A bias of Asparagine to Lysine mutations in SARS-CoV-2 outside the receptor binding domain affects protein flexibility
por: Boer, Jennifer C., et al.
Publicado: (2022)

Vaccination using mutated receptor binding domains of SARS-CoV-2: Evidence for partial immune escape but not serotype formation
por: Chang, Xinyue, et al.
Publicado: (2023)

SARS-CoV2 variant-specific replicating RNA vaccines protect from disease following challenge with heterologous variants of concern
por: Hawman, David W, et al.
Publicado: (2022)

Biophysical and Biochemical Characterization of the Receptor Binding Domain of SARS-CoV-2 Variants
por: Khatri, Ritika, et al.
Publicado: (2022)

Predicted Epitope Abundance Supports Vaccine-Induced Cytotoxic Protection Against SARS-CoV-2 Variants of Concern
por: Martín-Galiano, Antonio J., et al.
Publicado: (2021)

Third SARS-CoV-2 vaccination and breakthrough infections enhance humoral and cellular immunity against variants of concern
por: Ruhl, Louisa, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_kp0f5tennrpjcfmj9h109v7nnh